Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

280

HTML

1539

Figures (1-4)

150

Tables (1-1)

142

Sum=2111

Jan 7, 2010 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 7, 2010; 16(1): 112-118
Published online Jan 7, 2010. doi: 10.3748/wjg.v16.i1.112

Table 1 siRNA sequence

siRNA	From 5' to 3'
FAP-1 siRNA 1709	Sense: CGAAGGAAAGUAAACAUAATT
	Anti-sense: UUAUGUUUACUUUCCUUCGGT
FAP-1 siRNA 6267	Sense: CAGGUACAUUAAAGAUGAATT
	Anti-sense: UUCAUCUUUAAUGUACCUGGA
FAP-1 siRNA 3264	Sense: GGGAGAUCACCUUAGUGAATT
	Anti-sense: UUCACUAAGGUGAUCUCCCTT
GAPDH positive control	Sense: GUAUGACAACAGCCUCAAGTT
GAPDH positive control	Anti-sense: CUUGAGGCUGUUGUCAUACTT
Negative control	Sense: UUCUCCGAACGUGUCACGUTT
	Anti-sense: ACGUGACACGUUCGGAGAATT

siRNA: Small interfering RNA; FAP-1: Fas-associated phosphatase 1; GAPDH: Glyceraldehyde phosphate dehydrogenase.

Citation: Xiao ZY, Wu W, Eagleton N, Chen HQ, Shao J, Teng H, Liu TH, Jiang ZM, Yao HR. Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin. World J Gastroenterol 2010; 16(1): 112-118
URL: https://www.wjgnet.com/1007-9327/full/v16/i1/112.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i1.112